News 07 mai 2020 Bern synthetic coronavirus clone goes “viral” In mid-February, a team of researchers from the University of Bern succeeded in reconstructing a synthetic clone of the novel coronavirus using a...
News 23 mai 2023 University of Basel and RocketVax present new COVID vaccine Researchers from the University of Basel have developed a new concept for a COVID vaccine in collaboration with the biotech start-up RocketVax. I...
News 13 dez 2022 New Empa method indicates virus death in face masks With the help of a method developed at the Swiss Federal Laboratories for Materials Science and Technology (Empa), researchers can compare which ...
Aktuell 13 dez 2022 Neues Empa-Verfahren zeigt Virensterben in Masken Mithilfe eines an der Eidgenössischen Materialprüfungs- und Forschungsanstalt (Empa) entwickelten Verfahrens können Forschende vergleichen, welch...
Actualités 07 out 2020 Lonza produira le vaccin anti-Covid de Moderna dès décembre Le nouveau bâtiment de Lonza dédié à la production du vaccin contre le Covid-19 de Moderna sera opérationnel dès décembre 2020. 300 millions de d...
Actualités 24 mar 2020 Hamilton produit des appareils respiratoires à plein régime L’entreprise américaine de haute technologie Hamilton a son siège européen et son site de production le plus important dans la région métropolita...
Actualités 07 mai 2020 Le clone bernois du coronavirus devient « viral » Mi-février, une équipe de chercheurs de l'université de Berne est parvenue à reconstruire un clone synthétique du nouveau coronavirus grâce à un ...
Novità 24 mar 2020 Hamilton produce respiratori a pieno ritmo L’azienda hightech americana Hamilton ha la sua sede principale europea e il proprio principale stabilimento di produzione nella Greater Zurich A...
News 30 set 2021 Hamilton develops new swab device The medtech company Hamilton has developed an automated device for nasal and buccal swab collection in collaboration with the Harvard spin-off Rh...
News 27 out 2021 The University of Bern has developed a non-contagious SARS-CoV-2 model Researchers of the University of Bern and the Rockefeller University have developed a non-contagious SARS-CoV-2 model that makes it easier to cha...
Aktuell 30 set 2021 Hamilton entwickelt neues Abstrich-Testgerät Das Medtech-Unternehmen Hamilton hat gemeinsam mit der Harvard-Ausgründung Rhinostics ein automatisiertes Gerät zur Sammlung und Verarbeitung von...
Success stories 25 mai 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
ニュース 25 mar 2020 ロイバント・サイエンシズ社がコロナウィルス治療薬開発へ 2016年にスイス・バーゼル州に進出した製薬会社、ロイバント・サイエンシズ社(本社:英国・ロンドン)は、コロナウイルス治療に効果的な抗体の開発に取り組んでいます。コロナウィルス患者の典型的症状である急性呼吸窮迫症候群の治療と予防を目的としています。
Guide 26 mai 2021 Modern financing options for startups in the expansion phase This year's International Trade Forum at the end of April focused on the new normality in international business. The big meeting for internation...
News 19 mai 2020 Medela trebles production The MedTech firm Medela has more than trebled production of its respiratory tract suction pumps. This means the company has been able to react to...
News 29 jul 2020 University of Bern study provides insights into potential Sars-Cov-2 treatments An international team with researchers of the Institute of Virology and Immunology (IVI) of the University of Bern and the Swiss Federal Food Saf...
Ratgeber 26 mai 2021 Moderne Finanzierungsmöglichkeiten für Start-ups in der Expansionsphase Das Aussenwirtschaftsforum, welches Ende April 2021 stattfand, bot Inspiration und Rüstzeug für den Export von morgen – unter anderem hinsichtlic...
News 30 mar 2020 Roivant developing treatment for coronavirus patients The Basel-based pharmaceutical company Roivant Sciences wants to develop a special antibody for coronavirus patients. This is intended to help tr...